Krynica Vitamin S.A. (WSE: KVT)

Krynica Vitamin Statistics

Total Valuation

Krynica Vitamin has a market cap or net worth of PLN 101.45 million. The enterprise value is 139.42 million.

Market Cap	101.45M
Enterprise Value	139.42M

Important Dates

The next estimated earnings date is Thursday, April 24, 2025.

Earnings Date	Apr 24, 2025
Ex-Dividend Date	n/a

Share Statistics

Krynica Vitamin has 12.25 million shares outstanding. The number of shares has decreased by -0.01% in one year.

Current Share Class	n/a
Shares Outstanding	12.25M
Shares Change (YoY)	-0.01%
Shares Change (QoQ)	-0.01%
Owned by Insiders (%)	0.09%
Owned by Institutions (%)	1.92%
Float	1.61M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.27
PB Ratio	1.09
P/TBV Ratio	1.10
P/FCF Ratio	5.02
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 4.90, with an EV/FCF ratio of 6.90.

EV / Earnings	-86.87
EV / Sales	0.36
EV / EBITDA	4.90
EV / EBIT	9.36
EV / FCF	6.90

Financial Position

The company has a current ratio of 0.92, with a Debt / Equity ratio of 0.45.

Current Ratio	0.92
Quick Ratio	0.54
Debt / Equity	0.45
Debt / EBITDA	1.47
Debt / FCF	2.07
Interest Coverage	3.78

Financial Efficiency

Return on equity (ROE) is -1.71% and return on invested capital (ROIC) is 6.52%.

Return on Equity (ROE)	-1.71%
Return on Assets (ROA)	3.97%
Return on Capital (ROIC)	6.52%
Revenue Per Employee	1.14M
Profits Per Employee	-4,777
Employee Count	336
Asset Turnover	1.63
Inventory Turnover	8.66

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -44.83% in the last 52 weeks. The beta is -0.18, so Krynica Vitamin's price volatility has been lower than the market average.

Beta (5Y)	-0.18
52-Week Price Change	-44.83%
50-Day Moving Average	9.18
200-Day Moving Average	10.56
Relative Strength Index (RSI)	39.79
Average Volume (20 Days)	817

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Krynica Vitamin had revenue of PLN 382.75 million and -1.61 million in losses. Loss per share was -0.13.

Revenue	382.75M
Gross Profit	59.20M
Operating Income	14.89M
Pretax Income	-458,000
Net Income	-1.61M
EBITDA	28.46M
EBIT	14.89M
Loss Per Share	-0.13

Balance Sheet

The company has 3.95 million in cash and 41.93 million in debt, giving a net cash position of -37.98 million or -3.10 per share.

Cash & Cash Equivalents	3.95M
Total Debt	41.93M
Net Cash	-37.98M
Net Cash Per Share	-3.10
Equity (Book Value)	93.32M
Book Value Per Share	7.62
Working Capital	-8.32M

Cash Flow

In the last 12 months, operating cash flow was 29.92 million and capital expenditures -9.70 million, giving a free cash flow of 20.22 million.

Operating Cash Flow	29.92M
Capital Expenditures	-9.70M
Free Cash Flow	20.22M
FCF Per Share	1.65

Margins

Gross margin is 15.47%, with operating and profit margins of 3.89% and -0.42%.

Gross Margin	15.47%
Operating Margin	3.89%
Pretax Margin	-0.12%
Profit Margin	-0.42%
EBITDA Margin	7.43%
EBIT Margin	3.89%
FCF Margin	5.28%

Dividends & Yields

Krynica Vitamin does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.01%
Shareholder Yield	0.01%
Earnings Yield	-1.58%
FCF Yield	19.93%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Krynica Vitamin has an Altman Z-Score of 2.55. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.55
Piotroski F-Score	n/a